galantamine and Parkinsonian Disorders

galantamine has been researched along with Parkinsonian Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kishimoto, K; Kitamura, Y; Minamino, H; Shibaike, T; Shimohama, S; Takata, K; Takeuchi, H; Taniguchi, T; Tsushima, J; Yanagida, T; Yasui, H1
Abbas, SF; Baqi, Y; Chrobak, JJ; Collins, LE; Galtieri, DJ; Leser, CE; Müller, CE; Paul, NE; Podurgiel, SJ; Salamone, JD1
Edwards, K; Farlow, M; Hake, A; Hershey, L; Johnson, S; Lichter, D; Pasquier, F; Royall, D1

Trials

1 trial(s) available for galantamine and Parkinsonian Disorders

ArticleYear
Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
    Dementia and geriatric cognitive disorders, 2007, Volume: 23, Issue:6

    Topics: Aged; Aged, 80 and over; Behavioral Symptoms; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Female; Galantamine; Hallucinations; Humans; Lewy Body Disease; Male; Mental Status Schedule; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinsonian Disorders; Treatment Outcome

2007

Other Studies

2 other study(ies) available for galantamine and Parkinsonian Disorders

ArticleYear
Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.
    Neuroscience research, 2008, Volume: 62, Issue:4

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Functional Laterality; Galantamine; Gene Expression Regulation; Male; Mecamylamine; Methamphetamine; Motor Activity; Neuroprotective Agents; Nicotine; Nicotinic Antagonists; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Nicotinic; RNA, Messenger; Rotarod Performance Test; Tyrosine 3-Monooxygenase

2008
Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:3

    Topics: Alzheimer Disease; Animals; Cholinergic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electromyography; Galantamine; Jaw; Male; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tremor

2011